Skip to search formSkip to main contentSkip to account menu

LY 341311

Known as: LY-341311, LY341311 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

BDF 9148

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
Combined inotropic and bradycardic effects of a sodium channel enhancer in conscious dogs with heart failure: a mechanism for improved myocardial efficiency compared with dobutamine.
We compared the cardiac inotropic, chronotropic, and myocardial O(2) consumption (MVO(2)) responses to the sodium (Na(+)) channel… 
2002
2002
A sodium channel enhancer, LY341311, increases myocardial contractile performance without increasing heart rate in conscious normal dogs: a comparison with dobutamine.
BACKGROUND Catecholamines and many inotropic agents increase cardiac contractility but also cause excessive myocardial O2… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)